• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Delivery at 37 or 39 Weeks for Higher Order Cesarean Sections?

image_pdfFavoriteLoadingFavorite

BACKGROUND:

  • The increasing cesarean section rate has resulted in more women who have undergone multiple cesarean sections
    • Significant risks include intraperitoneal adhesions, hemorrhage and organ injury
  • The risks of unscheduled delivery need to be balanced against the risk of early term delivery
  • Miller et al. (American Journal of Perinatology 2018) assessed whether women undergoing a higher order cesarean (3 cesarean deliveries or more) had a difference in perinatal outcome based on timing of delivery

METHODS:

  • Retrospective cohort study
  • Participants: Women with singleton gestations and a history of three or more prior cesareans
  • Higher order cesareans were delivered at two centers
    • One center delivers at 39 weeks gestation
    • One center delivers at 37 weeks gestation (following after fetal lung maturity analysis or antenatal steroids)
  • Primary outcomes
    • maternal and neonatal morbidities
  • Adjustments were made for confounders, including maternal age, race/ethnicity, gravidity, parity, body mass index (BMI) at delivery, number of previous cesareans, concomitant major medical problems, indication for delivery (i.e., scheduled versus unscheduled), and gestational age at delivery

RESULTS:

  • 440 women met criteria
  • 2% of women were delivered at the 39 week institution vs 56.8% who delivered at the 37 week institution
  • Delivery at 37-weeks was associated with a decrease in unscheduled deliveries (15.3 vs. 41.1%; p < 0.001)
  • Planned delivery at 37 weeks was initially associated with decreased
    • Incidence of composite maternal morbidity (1.6 vs. 7.9%; p = 0.002)
    • 5-minute Apgar scores less than 7 (0.4 vs. 6.4%; p < 0.001),
  • These differences were no longer significant after adjusting for confounders
  • There were no other differences in perinatal outcomes

CONCLUSION:

  • There were no significant differences between delivery at 37- and 39 weeks gestation for maternal or neonatal outcome
  • However, delivery at 37 weeks did lead to fewer unscheduled deliveries
  • The current study was powered (80%) to detect a 10-fold increased incidence of bowel injury and a 5-fold increased incidence of transfusion but not more rare outcomes such as maternal death or hysterectomy
  • Authors recommend a well powered RCT to further determine impact on maternal and neonatal risks

Learn More – Primary Sources:

Optimal Timing of Delivery in Women with Higher Order Cesareans: A Cohort Study

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

What is the Best Practices Prevention Bundle for Post Cesarean Infection?
Does Vaginal Cleansing Prevent Endometritis Following Cesarean Section?
Does Azithromycin Cut Infection-associated Costs Following Cesarean Section?
Which is the Better Suture to Prevent C-Section Wound Complications? 

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site